secwatch.observer — SEC 8-K summary
======================================

Issuer:     ANGIODYNAMICS INC (ANGO)
CIK:        0001275187
Form:       8-K
Filed at:   2024-11-15T23:59:59+00:00
Accession:  0001140361-24-047071
Event type: other_material
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

AngioDynamics shareholders approve all proposals at 2024 annual meeting including equity plan amendment
--------------------------------------------------------------------------------

- Elected three Class III directors: Burgess, Johnson, Licitra each with >24.8M votes for, 5.99M broker non-votes.
- Ratified Deloitte & Touche as FY2025 auditor with 34.1M for, 155k against, 16.5k abstain.
- Advisory approval of exec compensation: 26.0M for, 1.25M against, 1.04M abstain, 5.99M broker non-votes.
- Approved amended 2020 Equity Incentive Plan increasing share reserve: 23.2M for, 5.06M against, 35k abstain, 5.99M broker non-votes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1275187/000114036124047071/0001140361-24-047071-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1275187/000114036124047071/ef20038737_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-24-047071

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer